Published in Scand J Rheumatol on January 01, 2000
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis (2003) 3.33
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis (2004) 3.23
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res (2001) 2.18
Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med (2008) 2.17
Risk, safety, and the dark side of quality. BMJ (1997) 5.68
Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care (2002) 5.52
An epigenetic mutation responsible for natural variation in floral symmetry. Nature (1999) 5.32
The bearded airway. Anaesthesia (1998) 4.69
Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity (2000) 4.44
Inflorescence commitment and architecture in Arabidopsis. Science (1997) 4.26
The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol (2001) 3.92
Origin of floral asymmetry in Antirrhinum. Nature (1996) 3.74
Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol (1988) 3.25
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis (2004) 3.23
The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol (1999) 3.22
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum (2001) 2.96
An evaluation of adverse incident reporting. J Eval Clin Pract (1999) 2.96
The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development (2001) 2.78
Control of organ asymmetry in flowers of Antirrhinum. Cell (1999) 2.74
A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet (1997) 2.68
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team. N Engl J Med (1999) 2.67
Control of inflorescence architecture in Antirrhinum. Nature (1996) 2.56
Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol (2001) 2.45
The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest (1995) 2.37
The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J Clin Invest (1993) 2.37
Exploring the causes of adverse events in NHS hospital practice. J R Soc Med (2001) 2.36
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol (2014) 2.28
Applying human factors methods to clinical risk management in obstetrics. Br J Obstet Gynaecol (1997) 2.24
Relationship of sequence and structure to specificity in the alpha-amylase family of enzymes. Biochim Biophys Acta (2001) 2.21
The prevalence of rheumatoid arthritis in Sweden. Scand J Rheumatol (1999) 2.20
Starch- and glycogen-debranching and branching enzymes: prediction of structural features of the catalytic (beta/alpha)8-barrel domain and evolutionary relationship to other amylolytic enzymes. J Protein Chem (1993) 2.15
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis (2004) 2.15
Case record review of adverse events: a new approach. Qual Saf Health Care (2003) 2.15
The association of workflow interruptions and hospital doctors' workload: a prospective observational study. BMJ Qual Saf (2011) 2.13
Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain. Ann Rheum Dis (1997) 1.95
The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol (1999) 1.93
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
Feedback from incident reporting: information and action to improve patient safety. Qual Saf Health Care (2009) 1.87
In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol (2000) 1.77
High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis (1989) 1.69
The safety of acupuncture. BMJ (2001) 1.62
Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol (1998) 1.60
Violations and migrations in health care: a framework for understanding and management. Qual Saf Health Care (2006) 1.60
Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol (1998) 1.59
Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet (1997) 1.59
Value of failure to rescue as a marker of the standard of care following reoperation for complications after colorectal resection. Br J Surg (2011) 1.59
The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrol Dial Transplant (2000) 1.56
Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis (2006) 1.54
A circularly permuted alpha-amylase-type alpha/beta-barrel structure in glucan-synthesizing glucosyltransferases. FEBS Lett (1996) 1.51
The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain (1992) 1.48
Purification of different amphiphilic forms of a microvillus aminopeptidase from pig small intestine using immunoadsorbent chromatography. Eur J Biochem (1978) 1.47
D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study. Clin Exp Rheumatol (1997) 1.44
Efficacy of essential oil of Ocimum basilicum L. and O. gratissimum L. applied as an insecticidal fumigant and powder to control Callosobruchus maculatus (Fab.) J Stored Prod Res (2001) 1.42
The impact of the Bosnian conflict on the health and mental health of New Zealanders. N Z Med J (1995) 1.40
The role of bone morphogenetic proteins in vertebral development. Development (1996) 1.39
Posterior reversible encephalopathy syndrome in a context of isolated cervical spine fracture: CT angiogram as an early detector of blunt carotid artery trauma. Orthop Traumatol Surg Res (2011) 1.38
Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci (1998) 1.37
A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis (2004) 1.36
A newly identified locus for Usher syndrome type I, USH1E, maps to chromosome 21q21. Hum Mol Genet (1997) 1.34
Control of flower development and phyllotaxy by meristem identity genes in antirrhinum. Plant Cell (1995) 1.34
Patient safety in developing countries: retrospective estimation of scale and nature of harm to patients in hospital. BMJ (2012) 1.33
Clinical complaints: a means of improving quality of care. Qual Health Care (1994) 1.32
Glucoamylases G1 and G2 from Aspergillus niger are synthesized from two different but closely related mRNAs. EMBO J (1984) 1.31
A super-secondary structure predicted to be common to several alpha-1,4-D-glucan-cleaving enzymes. Biochem J (1989) 1.31
Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis (1999) 1.30
Comparison of the domain-level organization of starch hydrolases and related enzymes. Biochem J (1991) 1.27
Glucoamylase: structure/function relationships, and protein engineering. Biochim Biophys Acta (2000) 1.27
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Br J Cancer (2011) 1.27
Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level. J Exp Med (1979) 1.27
Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis (1988) 1.25
Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol (2001) 1.24
Serum beta2-microglobulin in hemodialyzed patients. Nephron (1978) 1.23
Complexity, risk and simulation in learning procedural skills. Med Educ (2007) 1.22
Crystal and molecular structure of barley alpha-amylase. J Mol Biol (1994) 1.22
Risks of elective cardiac surgery: what do patients want to know? Heart (2001) 1.22
Domain evolution in the alpha-amylase family. J Mol Evol (1997) 1.21
Body size as an indicator of parasitoid quality in male and female Anagyrus kamali (Hymenoptera: Encyrtidae). Bull Entomol Res (2001) 1.21
The simulated operating theatre: comprehensive training for surgical teams. Qual Saf Health Care (2004) 1.18
The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin Exp Immunol (1986) 1.17
Anterior cephalic neural crest is required for forebrain viability. Development (1999) 1.15
Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis (2001) 1.15
Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection. Laryngoscope (2006) 1.15
Functional characterization of the low-molecular-mass phosphotyrosine-protein phosphatase of Acinetobacter johnsonii. J Mol Biol (1998) 1.14
The pragmatics of clinical hypermedia: experiences from 5 years of participatory design in the MEDEA project. Comput Methods Programs Biomed (1995) 1.14
Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (1995) 1.14
Trichorhinophalangeal syndrome type I: symptoms and signs, radiology and genetics. Ann Rheum Dis (1986) 1.13
Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis. Ann Rheum Dis (1993) 1.13
Site-directed mutagenesis of histidine 93, aspartic acid 180, glutamic acid 205, histidine 290, and aspartic acid 291 at the active site and tryptophan 279 at the raw starch binding site in barley alpha-amylase 1. J Biol Chem (1993) 1.13
Children at risk for asthma: home allergen levels, lymphocyte proliferation, and wheeze. J Allergy Clin Immunol (2000) 1.13
Characterization of a bacterial gene encoding an autophosphorylating protein tyrosine kinase. Gene (1997) 1.12
Plant alpha-glucosidases of the glycoside hydrolase family 31. Molecular properties, substrate specificity, reaction mechanism, and comparison with family members of different origin. Plant Mol Biol (1998) 1.12
Structural studies on the O-glycosidically linked carbohydrate chains of glucoamylase G1 from Aspergillus niger. Eur J Biochem (1984) 1.11
Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. J Immunol (1979) 1.10
IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol (2005) 1.10
Dynamic versus static training in patients with rheumatoid arthritis. Scand J Rheumatol (1990) 1.10